Bio-Rad Laboratories (BIO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Learn more about whether Bio-Rad Laboratories, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor ...

Malvern Instruments and Bio-Rad from Hercules, California, are collaborating to deliver new analytical tools for the rapid identification of ...

Learn more about whether Bio-Rad Laboratories, Inc. or Medpace Holdings, Inc. is a better investment based on AAII's A+ ...

Park Avenue Securities LLC increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...

Crossmark Global Holdings Inc. lowered its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 31.3% ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer ...